Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 84 Records) |
| Query Trace: Syndrome and ABCB1[original query] |
|---|
| Pharmacogenetics and prediction of adverse events in prescription opioid use disorder patients. Basic & clinical pharmacology & toxicology 2018 12 124 (4): 439-448. Muriel Javier, Margarit César, Barrachina Jordi, Ballester Pura, Flor Andrea, Morales Domingo, Horga José F, Fernández Eduardo, Peiró Ana |
| Association of CYP2C19 Polymorphism with Clopidogrel Resistance in Patients with Acute Coronary Syndrome in China. Medical science monitor : international medical journal of experimental and clinical research 2019 Sep 25 7138-7148. Su Qiang, Li Jian, Tang Zhili, Yang Siyun, Xing Guoqiang, Liu Tao, Peng Ho |
| Influence of CYP3A4/5 and ABC transporter polymorphisms on lenvatinib plasma trough concentrations in Japanese patients with thyroid cancer. Scientific reports 2019 Apr 9 (1): 5404. Ozeki Tomoko, Nagahama Mitsuji, Fujita Kazuma, Suzuki Akifumi, Sugino Kiminori, Ito Koichi, Miura Masato |
| Population pharmacokinetic study of tacrolimus in pediatric patients with primary nephrotic syndrome: A comparison of linear and nonlinear Michaelis-Menten pharmacokinetic model. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2019 Dec 143 105199. Huang Lingfei, Liu Yixi, Jiao Zheng, Wang Junyan, Fang Luo, Mao Jianh |
| Distribution of polymorphisms in the CYP2C19 and ABCB1 genes among patients with acute coronary syndrome in Lower Silesian population. Advances in clinical and experimental medicine : official organ Wroclaw Medical University 2019 11 28 (12): 1621-1626. Wójcik Tomasz, Szymkiewicz Pawe?, Wi?niewski Jerzy, Lebioda Arleta, Jonkisz Anna, Gamian Andrzej, Kuliczkowski Wiktor, ?ciborski Krzysztof, Mysiak Andrzej, Protasiewicz Marc |
| Both CYP2C19 and PON1 Q192R Genotypes Influence Platelet Response to Clopidogrel by Thrombelastography in Patients with Acute Coronary Syndrome. Cardiovascular therapeutics 2019 2019 3470145. Peng Wenxing, Shi Xiujin, Xu Xiaoyu, Lin Ya |
| Impact of CYP3A4/5 and ABCB1 polymorphisms on tacrolimus exposure and response in pediatric primary nephrotic syndrome. Pharmacogenomics 2019 10 20 (15): 1071-1083. Huang Lingfei, Wang Junyan, Yang Jufei, Zhang Huifen, Ni Yinghua, Zhu Zhengyi, Wang Huijuan, Gao Peng, Wu Yuanyuan, Mao Jianhua, Fang L |
| Relevance of Pharmacogenomics and Multidisciplinary Management in a Young-Elderly Patient With KRAS Mutant Colorectal Cancer Treated With First-Line Aflibercept-Containing Chemotherapy. Frontiers in oncology 2020 8 10 1155. Bruera Gemma, D'Andrilli Antonio, Simmaco Maurizio, Guadagni Stefano, Rendina Erino Angelo, Ricevuto Enri |
| Diltiazem on tacrolimus exposure and dose sparing in Chinese pediatric primary nephrotic syndrome: impact of CYP3A4, CYP3A5, ABCB1, and SLCO1B3 polymorphisms. European journal of clinical pharmacology 2020 Aug . Wang Junyan, Huang Lingfei, Gao Peng, Hu Yan, Ni Yinghua, Zhu Zhengyi, Zhang Liwen, Yang Jufei, Zhang Huifen, Fang L |
| CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban. Pharmacogenomics and personalized medicine 2020 3 13 29-37. Sychev D A, Baturina O A, Mirzaev K B, Rytkin E, Ivashchenko D V, Andreev D A, Ryzhikova K A, Grishina E A, Bochkov P O, Shevchenko R |
| Impact of Continuous P2Y12 Inhibition Tailoring in Acute Coronary Syndrome and Genetically Impaired Clopidogrel Absorption. Journal of cardiovascular pharmacology 2020 Feb 75 (2): 174-179. Samardzic Jure, Bozina Nada, Skoric Bosko, Ganoci Lana, Krpan Miroslav, Petricevic Mate, Pasalic Marijan, Bozina Tamara, Pavasovic Sasa, Cikes Maja, Milicic Dav |
| Effects of the ABCB1 C3435T single nucleotide polymorphism on major adverse cardiovascular events in acute coronary syndrome or coronary artery disease patients undergoing percutaneous coronary intervention and treated with clopidogrel: A systematic review and meta-analysis. Expert opinion on drug safety 2020 10 19 (12): 1605-1616. Biswas Mohitosh, Rahaman Shawonur, Biswas Tapash Kumar, Ibrahim Baharud |
| ABCB1 and DRD3 polymorphism as a response predicting biomarker and tool for pharmacogenetically guided clozapine dosing in Asian Indian treatment resistant schizophrenia patients. Asian journal of psychiatry 2019 Dec 48 101918. M Naveen, Patil Amol N, Pattanaik Smita, Kaur Anit, Banerjee Dibyajyoti, Grover Sande |
| The influence of acute coronary syndrome on levels of clopidogrel active metabolite and platelet inhibition in patients with and without CYP2C19*2(681 G>A), *3(636 G>A) and ABCB1(C3435C> T) gene polymorphisms. Postepy w kardiologii interwencyjnej = Advances in interventional cardiology 2021 Jun 17 (2): 179-186. Wójcik Tomasz, Karolko Bo?ena, Wi?niewski Jerzy, Mysiak Andrzej, ?ciborski Krzysztof, Onisk Grzegorz, Lebioda Arleta, Jonkisz Anna, Protasiewicz Marc |
| Pharmacogenetics of the Central Nervous System-Toxicity and Relapse Affecting the CNS in Pediatric Acute Lymphoblastic Leukemia. Cancers 2021 May 13 (10): . Sági Judit C, Gézsi András, Egyed Bálint, Jakab Zsuzsanna, Benedek Noémi, Attarbaschi Andishe, Köhrer Stefan, Sipek Jakub, Winkowska Lucie, Zaliova Marketa, Anastasopoulou Stavroula, Wolthers Benjamin Ole, Ranta Susanna, Szalai Csaba, Kovács Gábor T, Semsei Ágnes F, Erdélyi Dániel |
| The effects of polymorphisms in CYP2C19, ATP-binding cassette transporter B1, and paraoxonase-1 on clopidogrel treatment of Uygur patients following percutaneous coronary intervention. European journal of clinical pharmacology 2021 6 77 (11): 1679-1686. Wang Tingting, Li Hongjian, Wang Fengxia, Sun Li, Yu Luh |
| Original and generic clopidogrel: A comparison of antiplatelet effects and active metabolite concentrations in patients without polymorphisms in the ABCB1 gene and the allele variants CYPC19*2 and *3. Advances in clinical and experimental medicine : official organ Wroclaw Medical University 2021 May . Wójcik Tomasz, Szymkiewicz Pawe?, ?ciborski Krzysztof, ?ukaszewski Marceli, Onisk Grzegorz, Mysiak Andrzej, Gamian Andrzej, Wi?niewski Jerzy, Dobosz Tadeusz, Lebioda Arleta, Jonkisz Anna, Protasiewicz Marc |
| A Systematic Review and Meta-Analysis of Pharmacogenetic Studies in Patients with Chronic Kidney Disease. International journal of molecular sciences 2021 4 22 (9): . Tziastoudi Maria, Pissas Georgios, Raptis Georgios, Cholevas Christos, Eleftheriadis Theodoros, Dounousi Evangelia, Stefanidis Ioannis, Theoharides Theoharis |
| Meta-Analysis of ABCG2 and ABCB1 Polymorphisms With Sunitinib-Induced Toxicity and Efficacy in Renal Cell Carcinoma. Frontiers in pharmacology 2021 3 12 641075. Sun Fengjun, Chen Zhuo, Yao Pu, Weng Bangbi, Liu Zhirui, Cheng L |
| Assessment of the Link of ABCB1 and NR3C1 gene polymorphisms with the prednisolone resistance in pediatric nephrotic syndrome patients of Bangladesh: A genotype and haplotype approach. Journal of advanced research 2021 Nov 33 141-151. Parvin Most Nazma, Aziz Md Abdul, Rabbi Sikder Nahidul Islam, Al-Mamun Mir Md Abdullah, Hanif Mohammed, Islam Md Saiful, Islam Mohammad Safiq |
| The role of ABCB1 gene polymorphisms in steroid-resistant nephrotic syndrome: Evidence from a meta-analysis of steroid-receiving patients. The journal of gene medicine 2022 Jun e3436. Aziz Md Abdul, Islam Mohammad Safiq |
| The influence of methotrexate-related transporter and metabolizing enzyme gene polymorphisms on peri-engraftment syndrome and graft-versus-host disease after haplo-hematopoietic stem cell transplantation in pediatric patients with malignant hematological diseases. Frontiers in immunology 2023 9 14 1229266. Qi Ji, Yongping Zhang, Yixin Hu, Lixia Liu, Shanbo Cao, Li Gao, Bohan Li, Yuanyuan Tian, Lingjun Kong, Shuiyan Wu, Jing Ling, Peifang Xiao, Jun Lu, Jie Li, Yanhua Yao, Jiayue Qin, Shaoyan |
| Pilot Study on the Impact of Polymorphisms Linked to Multi-Kinase Inhibitor Metabolism on Lenvatinib Side Effects in Patients with Advanced Thyroid Cancer. International journal of molecular sciences 2023 3 24 (6): . Cantara Silvia, Dalmiglio Cristina, Marzocchi Carlotta, Sagnella Alfonso, Brilli Lucia, Trimarchi Andrea, Maino Fabio, Valerio Laura, Castagna Maria Graz |
| Influence of CYP450 Enzymes and ABCB1 Polymorphisms on Clopidogrel Response in Moroccan Patients with Acute Coronary Syndromes. Pharmacogenomics and personalized medicine 2023 10 16 901-909. Ismail Mouhrach, Laila Bouguenouch, Adil Kamal, Abbassi Meriame, Nada El Khorb, Mohammed El Azami El Idrissi, Hafid Akoudad, Hicham Bekka |
| Clinical Value of ABCB1 and PAI-1 Gene Polymorphisms in Predicting Glucocorticoid-induced Adverse Reactions in Nephrotic Syndrome Patients. Current medical science 2024 9 . Ya-Ling Zhai, Shuai-Gang Sun, Wen-Hui Zhang, Hui-Juan Tian, Zhan-Zheng Zh |
| An accurate haplotyping method using multiplex pyrosequencing with AS-PCR to detect ABCB1 haplotypes associated with rivaroxaban-derived hemorrhagic events. Talanta 2024 9 281 126861. Shanshan Wang, Liteng Wang, Meng Wei, Lingfei Wang, Ziyun Yang, Chen Chen, Xueping Ma, Yana Chu, Haiping Wu, Guohua Zh |
| Association of ABCB1(Rs10276036, C/T) Gene, IL-18, and TNF? as Risk Factors for Nephrotic Syndrome Incidence. Reports of biochemistry & molecular biology 2024 11 13 (1): 67-78. Eglal Aly Hassan, Afaf Mohamed Elsaid, Ahmed Mahmoud El-Refaey, Mohammed Abou Elzahab, Magdy Mahfouz Youssef, Rehab Elmou |
| Increased plasma imatinib exposure and toxicity in chronically treated GIST patients with SARS-CoV-2 infection: a case series. Frontiers in immunology 2024 10 15 1441620. Sara Gagno, Bianca Posocco, Marco Orleni, Eleonora Cecchin, Arianna Fumagalli, Michela Guardascione, Angela Buonadonna, Jerry Polesel, Fabio Puglisi, Giuseppe Toffoli, Erika Cecch |
| Rivaroxaban for Thromboembolism Prophylaxis in Patients with Nephrotic Syndrome: A Single-Arm, Prospective Study. Kidney diseases (Basel, Switzerland) 2024 10 10 (5): 346-358. Meng Wei, Xue Wu, Liteng Wang, Zhichun Gu, Yuanmao Tu, Lihua Zhang, Jiong Zhang, Honglang Xie, Qing Zhou, Yanan Chu, Zhen Cheng, Guohua Zhou, Qinxin So |
| The Effect of Platelet Activity, ABCB1 Genetic Polymorphism, and Renal Function on the Development of Ticagrelor-Related Dyspnea in Patients with Acute Coronary Syndrome. Drug design, development and therapy 2024 1 18 109-119. Vytenis Tamakauskas, Remigijus Žali?nas, Vaiva Lesauskait?, Nora Kupstyt?-Krištapon?, Ieva ?iapien?, Gintar? Šakalyt?, Jurgita Plisien?, Vilius Skipskis, Vacis Tatar?n |
- Page last reviewed:Feb 1, 2024
- Content source: